SUNPHARM Pharmaceuticals (SUNP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SUNPHARM Pharmaceuticals (SUNP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Alys Hall who wrote (4)	10/31/1997 11:18:00 AM
From: F. Jay Abella, III	Read Replies (1) of 52

Did you see this? HERE'S SOME INTERESTING NEWS FOR FOLLOWERS OF SUNPHARM (NSDQ:SUNP). Shaman Pharmaceuticals Inc, a competitor to SunPharm, said it saw "positive results" from a pilot study on the drug Provir's ability to treat diarrhea in AIDS patients. However, in an interim analysis of a double-blind, placebo-controlled, mild diarrhea study of non-specific causes in 166 Mexican patients, the data did not support further studies of Provir in this particular mild diarrhea indication. The results of the pilot study of Provir used to treat AIDS-related diarrhea show there may be additional benefit gained by a longer treatment period. We visited Shaman in July. Here is what we stated July 31, "After seeing Shaman's corporate presentation, we think that SUNP has less competition [in the AIDS related diarrhea area] than originally thought." This sentiment is now absolutely true to us, as SHMN's product, if chronically administered, will not be competitive with the SUNP product for ARD.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next